BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 22960427)

  • 41. Analysis of risk factors for hepatocellular carcinoma in patients with HBs antigen- and anti-HCV antibody-negative alcoholic cirrhosis: clinical significance of prior hepatitis B virus infection.
    Uetake S; Yamauchi M; Itoh S; Kawashima O; Takeda K; Ohata M
    Alcohol Clin Exp Res; 2003 Aug; 27(8 Suppl):47S-51S. PubMed ID: 12960507
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Impact of hepatitis B and C virus infection on the clinical prognosis of alcoholic liver cirrhosis.
    Yamanaka T; Shiraki K; Nakazaawa S; Okano H; Ito T; Deguchi M; Takase K; Nakano T
    Anticancer Res; 2001; 21(4B):2937-40. PubMed ID: 11712790
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Outcome of hepatitis C virus infection in Chinese paid plasma donors: a 12-19-year cohort study.
    Rao HY; Sun DG; Yang RF; Liu F; Wang J; Feng B; Wu N; Fang JL; Song GJ; Ma H; Guo F; Wang JH; Li XB; Jin Q; Qin H; Zhuang H; Wei L
    J Gastroenterol Hepatol; 2012 Mar; 27(3):526-32. PubMed ID: 21871021
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Hepatitis C virus infection among a cohort of Victorian injecting drug users.
    Crofts N; Hopper JL; Bowden DS; Breschkin AM; Milner R; Locarnini SA
    Med J Aust; 1993 Aug; 159(4):237-41. PubMed ID: 7692222
    [TBL] [Abstract][Full Text] [Related]  

  • 45. A comparison of the prevalence of autoantibodies in individuals with chronic hepatitis C and those with autoimmune hepatitis: the role of interferon in the development of autoimmune diseases.
    Bayraktar Y; Bayraktar M; Gurakar A; Hassanein TI; Van Thiel DH
    Hepatogastroenterology; 1997; 44(14):417-25. PubMed ID: 9164512
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [The seroprevalence of HCV among injecting drug users in the years 2004-2008 in Slovakia].
    Gazdíková K; Gazdík F; Kajaba I; Hučková D; Okruhlica L; Farkašová D
    Vnitr Lek; 2012 Mar; 58(3):179-82. PubMed ID: 22486282
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Routes of infection, viremia, and liver disease in blood donors found to have hepatitis C virus infection.
    Conry-Cantilena C; VanRaden M; Gibble J; Melpolder J; Shakil AO; Viladomiu L; Cheung L; DiBisceglie A; Hoofnagle J; Shih JW
    N Engl J Med; 1996 Jun; 334(26):1691-6. PubMed ID: 8637513
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Comparison of the clinical characteristics among hepatocellular carcinoma of hepatitis B, hepatitis C and non-B non-C patients.
    Dohmen K; Shigematsu H; Irie K; Ishibashi H
    Hepatogastroenterology; 2003; 50(54):2022-7. PubMed ID: 14696457
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Impact of chronic hepatitis C virus (HCV) on survival of schizophrenic patients with co-occurring substance use disorders followed for ten years].
    Gimelfarb Y; Becalel E; Wolf A; Ben-Tzarfati M; Baruch Y
    Harefuah; 2014 Nov; 153(11):641-5, 688. PubMed ID: 25563021
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Mortality among persons in care with hepatitis C virus infection: the Chronic Hepatitis Cohort Study (CHeCS), 2006-2010.
    Mahajan R; Xing J; Liu SJ; Ly KN; Moorman AC; Rupp L; Xu F; Holmberg SD;
    Clin Infect Dis; 2014 Apr; 58(8):1055-61. PubMed ID: 24523214
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Burden of Hepatitis C in Iran Between 1990 and 2010: findings from the Global Burden of Disease Study 2010.
    Mohaghegh Shalmani H; Noori A; Shokoohi M; Khajavi A; Darvishi M; Delavari A; Jamshidi HR; Naderimagham S
    Arch Iran Med; 2015 Aug; 18(8):508-14. PubMed ID: 26265519
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Liver-related deaths in HIV-infected patients between 1995 and 2010 in France: the Mortavic 2010 study in collaboration with the Agence Nationale de Recherche sur le SIDA (ANRS) EN 20 Mortalité 2010 survey.
    Rosenthal E; Roussillon C; Salmon-Céron D; Georget A; Hénard S; Huleux T; Gueit I; Mortier E; Costagliola D; Morlat P; Chêne G; Cacoub P;
    HIV Med; 2015 Apr; 16(4):230-9. PubMed ID: 25522874
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Trends in mortality after diagnosis of hepatitis C virus infection: an international comparison and implications for monitoring the population impact of treatment.
    Aspinall EJ; Hutchinson SJ; Janjua NZ; Grebely J; Yu A; Alavi M; Amin J; Goldberg DJ; Innes H; Law M; Walter SR; Krajden M; Dore GJ
    J Hepatol; 2015 Feb; 62(2):269-77. PubMed ID: 25200903
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Sex difference in liver-related mortality and transplantation associated with dietary cholesterol in chronic hepatitis C virus infection.
    Yu L; Morishima C; Ioannou GN
    Br J Nutr; 2016 Jan; 115(2):193-201. PubMed ID: 26541123
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Chronic hepatitis C virus infection is associated with all-cause and liver-related mortality in a cohort of HIV-infected patients with alcohol problems.
    Fuster D; Cheng DM; Quinn EK; Nunes D; Saitz R; Samet JH; Tsui JI
    Addiction; 2014 Jan; 109(1):62-70. PubMed ID: 24112091
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The influence of hepatitis C and alcohol on liver-related morbidity and mortality in Glasgow's injecting drug user population.
    McDonald SA; Hutchinson SJ; Mills PR; Bird SM; Cameron S; Dillon JF; Goldberg DJ
    J Viral Hepat; 2011 Apr; 18(4):e126-33. PubMed ID: 20964793
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Lower life expectancy among people with an HCV notification: a population-based linkage study.
    Alavi M; Law MG; Grebely J; Thein HH; Walter S; Amin J; Dore GJ
    J Viral Hepat; 2014 Jun; 21(6):e10-8. PubMed ID: 24827903
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Therapy for hepatitis C virus infection increases survival of patients with pretreatment anemia.
    Mohanty A; Erqou S; McGinnis KA; Vanasse G; Freiberg MS; Sherman KE; Butt AA
    Clin Gastroenterol Hepatol; 2013 Jun; 11(6):741-7.e3. PubMed ID: 23376794
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Temporal trends in mortality among people who use drugs compared with the general Dutch population differ by hepatitis C virus and HIV infection status.
    van Santen DK; van der Helm JJ; Grady BP; de Vos AS; Kretzschmar ME; Stolte IG; Prins M
    AIDS; 2014 Nov; 28(17):2589-99. PubMed ID: 25211439
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Substance use and risk of death in young offenders: a prospective data linkage study.
    Kinner SA; Degenhardt L; Coffey C; Hearps S; Spittal M; Sawyer SM; Patton GC
    Drug Alcohol Rev; 2015 Jan; 34(1):46-50. PubMed ID: 25066461
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.